HES6 drives a critical AR transcriptional programme to induce castration‐resistant prostate cancer through activation of an E2F1‐mediated cell cycle network (EMBO Molecular Medicine, 2014)

(untitled) - Ramos-Montoya, A; Lamb, A; Russell, R; Carroll, T; Jurmeister, S; Galeano-Dalmau, N; Massie, C; Boren, J; Bon, H; Theodorou, V; Vias, M; Shaw, G; et al.